HLA- B*5701 typing:: evaluation of an allele-specific polymerase chain reaction melting assay

被引:32
作者
Hammond, E.
Mamotte, C.
Nolan, D.
Mallal, S.
机构
[1] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia
[2] Murdoch Univ, Perth, WA, Australia
[3] Curtin Univ Technol, Sch Biomed Sci, Bentley, WA 6102, Australia
来源
TISSUE ANTIGENS | 2007年 / 70卷 / 01期
关键词
abacavir; allele-specific polymerase; chain reaction; HLA-B*5701 genotyping; hypersensitivity reaction; melting curve;
D O I
10.1111/j.1399-0039.2007.00840.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Inheritance of HLA-B*5701 is a strong predictor of a hypersensitivity reaction to the anti-HIV drug abacavir. The identification of susceptible individuals prior to the institution of abacavir therapy is therefore of clinical importance and has generated demand for a simple and rapid diagnostic test for carriage of HLA-B*5701. In this study, we describe the development of such a method based on allele-specific polymerase chain reaction (AS-PCR) and melting curve analysis. Ninety-six patient samples including 36 HLA-B*5701-positive samples and 60 HLA-B*5701-negative samples were analysed. Compared with sequence-based typing, this method had 100% sensitivity and specificity for the HLA-B*5701 allele. In conclusion, the AS-PCR/melting curve approach minimises post-polymerase chain reaction handling processing and provides an attractive alternative to currently described AS-PCR methods.
引用
收藏
页码:58 / 61
页数:4
相关论文
共 9 条
[1]   Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir [J].
Cutrell, AG ;
Hernandez, JE ;
Fleming, JW ;
Edwards, MT ;
Moore, MA ;
Brothers, CH ;
Scott, TR .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) :2171-2172
[2]  
Hammond E, 2007, LEUKEMIA, V21, P817, DOI 10.1038/sj.leu.2404569
[3]   Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir [J].
Hetherington, S ;
McGuirk, S ;
Powell, G ;
Cutrell, A ;
Naderer, O ;
Spreen, B ;
Lafon, S ;
Pearce, G ;
Steel, H .
CLINICAL THERAPEUTICS, 2001, 23 (10) :1603-1614
[4]   HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing [J].
Martin, AM ;
Nolan, D ;
Mallal, S .
TISSUE ANTIGENS, 2005, 65 (06) :571-574
[5]   Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant [J].
Martin, AM ;
Nolan, D ;
Gaudieri, S ;
Almeida, CA ;
Nolan, R ;
James, I ;
Carvalho, F ;
Phillips, E ;
Christiansen, FT ;
Purcell, AW ;
McCluskey, J ;
Mallal, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) :4180-4185
[6]   Comparison of SYT09 and SYBR Green I for real-time polymerase chain reaction and investigation of the effect of dye concentration on amplification and DNA melting curve analysis [J].
Monis, PT ;
Giglio, S ;
Saint, CP .
ANALYTICAL BIOCHEMISTRY, 2005, 340 (01) :24-34
[7]   Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV Cohort study [J].
Rauch, A. ;
Nolan, D. ;
Martin, A. ;
McKinnon, E. ;
Almeida, C. ;
Mallal, Simon .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) :99-102
[8]  
Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]
[9]   Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe [J].
Witt, CS ;
Price, R ;
Kaur, G ;
Cheong, K ;
Kanga, U ;
Christiansen, F ;
Sayer, D ;
Mehra, NK .
TISSUE ANTIGENS, 2002, 60 (06) :474-480